Compare PROF & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | MNTK |
|---|---|---|
| Founded | N/A | 1980 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.5M | 202.0M |
| IPO Year | 2017 | 2020 |
| Metric | PROF | MNTK |
|---|---|---|
| Price | $6.80 | $1.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $1.80 |
| AVG Volume (30 Days) | 75.8K | ★ 176.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $16,098,000.00 | ★ $176,382,000.00 |
| Revenue This Year | $92.40 | $18.55 |
| Revenue Next Year | $64.10 | $12.68 |
| P/E Ratio | ★ $36.63 | $146.00 |
| Revenue Growth | ★ 50.73 | 0.37 |
| 52 Week Low | $3.92 | $1.07 |
| 52 Week High | $8.95 | $2.57 |
| Indicator | PROF | MNTK |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 56.83 |
| Support Level | $6.43 | $1.55 |
| Resistance Level | $7.06 | $1.72 |
| Average True Range (ATR) | 0.38 | 0.09 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 31.75 | 83.64 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.